Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Llibre

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
HIV Medicine|March 29, 2023
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohortJorge Palacio-Vieira, Sergio Moreno-Fornés, Yesika Díaz, et al.
Vaccines|January 22, 2024
Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, SpainDaniel Kwakye Nomah, Juliana Reyes-Urueña, Lucía Alonso, et al.
The New England Journal of Medicine|July 21, 2015
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection, Jens D Lundgren, Abdel G Babiker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 StudyHernando Knobel, José M Miró, Beatriz Mahillo, et al.
Microorganisms|November 25, 2023
Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide StudyRaquel Martín-Iguacel, Carles Pericas, Andreu Bruguera, et al.
International Journal of STD & AIDS|August 15, 2024
Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIVJorge Palacio-Vieira, Yesika Díaz, Sergio Moreno-Fornés, et al.
AIDS (London, England)|December 8, 2022
The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in EuropeAmanda Mocroft, Adam Geressu, Charles Beguelin, et al.
HIV Medicine|December 10, 2021
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA studyAmanda Mocroft, Jose M Miro, Gilles Wandeler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 13, 2025
Therapeutic response to an empirical praziquantel treatment in long-staying sub-Saharan African migrants with positive Schistosoma serology and chronic symptoms: A prospective cohort study in SpainSílvia Roure, Xavier Vallès, Olga Pérez-Quílez, et al.
AIDS (London, England)|July 18, 2020
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAmanda Mocroft, Lene Ryom, Cristiana Oprea, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
HIV Medicine|March 29, 2023
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohortJorge Palacio-Vieira, Sergio Moreno-Fornés, Yesika Díaz, et al.
Vaccines|January 22, 2024
Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, SpainDaniel Kwakye Nomah, Juliana Reyes-Urueña, Lucía Alonso, et al.
The New England Journal of Medicine|July 21, 2015
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection, Jens D Lundgren, Abdel G Babiker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 StudyHernando Knobel, José M Miró, Beatriz Mahillo, et al.
Microorganisms|November 25, 2023
Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide StudyRaquel Martín-Iguacel, Carles Pericas, Andreu Bruguera, et al.
International Journal of STD & AIDS|August 15, 2024
Developing and validating a clinical risk score to predict losses in the PISCIS cohort of people with HIVJorge Palacio-Vieira, Yesika Díaz, Sergio Moreno-Fornés, et al.
AIDS (London, England)|December 8, 2022
The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in EuropeAmanda Mocroft, Adam Geressu, Charles Beguelin, et al.
HIV Medicine|December 10, 2021
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA studyAmanda Mocroft, Jose M Miro, Gilles Wandeler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 13, 2025
Therapeutic response to an empirical praziquantel treatment in long-staying sub-Saharan African migrants with positive Schistosoma serology and chronic symptoms: A prospective cohort study in SpainSílvia Roure, Xavier Vallès, Olga Pérez-Quílez, et al.
AIDS (London, England)|July 18, 2020
Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive personsAmanda Mocroft, Lene Ryom, Cristiana Oprea, et al.
Pageof 17